Literature DB >> 10471613

The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest.

J P Kress1, A S Pohlman, J Alverdy, J B Hall.   

Abstract

Oxygen consumption dedicated to respiratory work (V O(2RESP)) during quiet breathing is small in normal patients. In the morbidly obese, at high minute ventilations, VO(2RESP) is greater than in normal patients, but VO(2RESP) during quiet breathing in these patients is not known. We postulated that such patients have increased VO(2RESP) at rest which may predispose them to respiratory failure when additional respiratory workloads are imposed. We measured baseline VO(2) in morbidly obese patients immediately prior to gastric bypass surgery and again after intubation, mechanical ventilation, and paralysis, and compared their change in VO(2) to nonobese patients scheduled for elective abdominal surgery. Baseline VO(2) was higher in the obese patients compared with control patients (354.6 versus 221.4 ml/min; p = 0.0001) and the change in VO(2) from spontaneous breathing to mechanical ventilation was significant in the obese patients (354.6 versus 297.2 ml/min; p = 0.0002) but not the control patients (221.4 versus 219.8 ml/min; p = 0.86). We conclude that morbidly obese patients dedicate a disproportionately high percentage of total VO(2) to conduct respiratory work, even during quiet breathing. This relative inefficiency suggests a decreased ventilatory reserve and a predisposition to respiratory failure in the setting of even mild pulmonary or systemic insults.

Entities:  

Mesh:

Year:  1999        PMID: 10471613     DOI: 10.1164/ajrccm.160.3.9902058

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  65 in total

Review 1.  Obesity, respiratory function and breathlessness.

Authors:  G J Gibson
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

2.  Oxygen cost of breathing and breathlessness during exercise in nonobese women and men.

Authors:  Santiago Lorenzo; Tony G Babb
Journal:  Med Sci Sports Exerc       Date:  2012-06       Impact factor: 5.411

3.  Impact of Weight Extremes on Clinical Outcomes in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Shan L Ward; Virginia Gildengorin; Stacey L Valentine; Anil Sapru; Martha A Q Curley; Neal Thomas; Douglas F Willson; Heidi R Flori
Journal:  Crit Care Med       Date:  2016-11       Impact factor: 7.598

4.  Metabolic and muscular factors limiting aerobic exercise in obese subjects.

Authors:  Filippo Vaccari; Mirco Floreani; Gabriella Tringali; Roberta De Micheli; Alessandro Sartorio; Stefano Lazzer
Journal:  Eur J Appl Physiol       Date:  2019-06-11       Impact factor: 3.078

5.  Obesity is associated with increased morbidity but not mortality in critically ill patients.

Authors:  Yasser Sakr; Christian Madl; Daniela Filipescu; Rui Moreno; Johan Groeneveld; Antonio Artigas; Konrad Reinhart; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

6.  Obesity and respiratory diseases.

Authors:  Christopher Zammit; Helen Liddicoat; Ian Moonsie; Himender Makker
Journal:  Int J Gen Med       Date:  2010-10-20

7.  The energy cost of cycling and aerobic performance of obese adolescent girls.

Authors:  C L Lafortuna; F Agosti; C Busti; R Galli; A Sartorio
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

8.  Aerobic exercise training without weight loss reduces dyspnea on exertion in obese women.

Authors:  Vipa Bernhardt; Jonathon L Stickford; Dharini M Bhammar; Tony G Babb
Journal:  Respir Physiol Neurobiol       Date:  2015-11-28       Impact factor: 1.931

Review 9.  Altered resting and exercise respiratory physiology in obesity.

Authors:  Akshay Sood
Journal:  Clin Chest Med       Date:  2009-09       Impact factor: 2.878

10.  Efficacy of a conservative weight loss program in the long-term management of chronic upper airway obstruction.

Authors:  Ryan C Case; John Schweinfurth
Journal:  Int J Otolaryngol       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.